Operaciones Merck KGaA - EUR - MRKd CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.65 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024161% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.020283% | ||||||||
| Horario tarifa nocturna | 22:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | EUR | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | Germany | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Merck KGaA ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Estadísticas clave
| Cierre previo* | 182 |
| Abrir* | 184.85 |
| Cambio de 1 año* | -2.97% |
| Rango del día* | 181.35 - 185.4 |
| Rango de 52 semanas | 153.10-202.80 |
| Volumen medio (10 días) | 304.81K |
| Volumen medio (3 meses) | 6.16M |
| Capitalización de mercado | 23.61B |
| Ratio P/E | 22.89 |
| Acciones en circulación | 434.78M |
| Ingresos | 21.79B |
| EPS | 7.98 |
| Dividendo (Rendimiento %) | 1.01287 |
| Beta | 0.58 |
| Próxima fecha de resultados | Mar 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Feb 7, 2023 | 182.00 | -0.85 | -0.46% | 182.85 | 185.40 | 181.40 |
| Feb 6, 2023 | 184.25 | -0.30 | -0.16% | 184.55 | 186.55 | 184.15 |
| Feb 3, 2023 | 185.80 | 3.60 | 1.98% | 182.20 | 186.25 | 181.00 |
| Feb 2, 2023 | 183.70 | 4.20 | 2.34% | 179.50 | 184.80 | 179.45 |
| Feb 1, 2023 | 181.80 | -7.00 | -3.71% | 188.80 | 188.85 | 181.10 |
| Jan 31, 2023 | 190.75 | -2.60 | -1.34% | 193.35 | 193.55 | 189.65 |
| Jan 30, 2023 | 193.60 | 4.10 | 2.16% | 189.50 | 194.05 | 188.95 |
| Jan 27, 2023 | 190.05 | -1.40 | -0.73% | 191.45 | 191.90 | 189.55 |
| Jan 26, 2023 | 192.30 | -1.90 | -0.98% | 194.20 | 195.45 | 192.30 |
| Jan 25, 2023 | 190.45 | 1.65 | 0.87% | 188.80 | 191.00 | 187.15 |
| Jan 24, 2023 | 189.45 | -2.55 | -1.33% | 192.00 | 192.75 | 188.80 |
| Jan 23, 2023 | 192.55 | 3.30 | 1.74% | 189.25 | 193.05 | 188.45 |
| Jan 20, 2023 | 186.55 | -1.80 | -0.96% | 188.35 | 191.20 | 186.50 |
| Jan 19, 2023 | 189.35 | -1.50 | -0.79% | 190.85 | 191.00 | 186.80 |
| Jan 18, 2023 | 192.35 | -3.95 | -2.01% | 196.30 | 196.40 | 192.15 |
| Jan 17, 2023 | 196.00 | -2.70 | -1.36% | 198.70 | 198.75 | 195.40 |
| Jan 16, 2023 | 199.20 | 1.15 | 0.58% | 198.05 | 200.00 | 197.85 |
| Jan 13, 2023 | 197.65 | 2.45 | 1.26% | 195.20 | 197.75 | 193.15 |
| Jan 12, 2023 | 196.75 | -3.15 | -1.58% | 199.90 | 200.30 | 192.85 |
| Jan 11, 2023 | 200.70 | 6.95 | 3.59% | 193.75 | 202.20 | 193.55 |
Merck KGaA - EUR Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Ingresos totales | 15024 | 14517 | 14836 | 16152 | 17534 | 19687 |
| Ingresos | 15024 | 14517 | 14836 | 16152 | 17534 | 19687 |
| Coste de los ingresos, total | 5201 | 5071 | 5342 | 5951 | 6782 | 7325 |
| Beneficio bruto | 9823 | 9446 | 9494 | 10201 | 10752 | 12362 |
| Gastos totales de explotación | 12543 | 12094 | 13109 | 14032 | 14549 | 15508 |
| Gastos de venta/general/administración Gastos, total | 4409 | 4234 | 4256 | 4686 | 4600 | 4855 |
| Investigación y desarrollo | 1972 | 2102 | 2220 | 2239 | 2262 | 2400 |
| Depreciation / Amortization | 1036 | 1020 | 979 | 923 | 636 | 589 |
| Gasto (ingreso) por intereses - Explotación neta | 57 | 3 | 62 | 1 | ||
| Gastos (ingresos) extraordinarios | -46 | -26 | 339 | 389 | 85 | 184 |
| Other Operating Expenses, Total | -86 | -310 | -89 | -156 | 184 | 154 |
| Ingresos de explotación | 2481 | 2423 | 1727 | 2120 | 2985 | 4179 |
| Ingresos por intereses (gastos), netos No operativos | -274 | -243 | -209 | -338 | -350 | -255 |
| Otros, netos | -53 | -51 | -57 | -47 | -5 | 0 |
| Ingresos netos antes de impuestos | 2154 | 2129 | 1461 | 1735 | 2630 | 3924 |
| Ingresos netos después de impuestos | 1633 | 2557 | 1093 | 1295 | 1993 | 3065 |
| Intereses menores | -4 | -10 | -22 | -3 | -7 | -10 |
| Beneficio neto antes de partidas extra. Elementos | 1629 | 2547 | 1071 | 1292 | 1986 | 3055 |
| Total de partidas extraordinarias | 0 | 57 | 2303 | 28 | 0 | |
| Ingresos netos | 1629 | 2604 | 3374 | 1320 | 1986 | 3055 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 1629 | 2548 | 1071 | 1292 | 1987 | 3055 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 1629 | 2605 | 3374 | 1320 | 1987 | 3055 |
| Beneficio neto diluido | 1629 | 2605 | 3374 | 1320 | 1987 | 3055 |
| Promedio ponderado de acciones diluidas | 434.778 | 434.778 | 434.794 | 434.211 | 434.792 | 434.566 |
| BPA diluido sin partidas extraordinarias | 3.74674 | 5.86046 | 2.46324 | 2.97552 | 4.57 | 7.03 |
| Dividends per Share - Common Stock Primary Issue | 1.2 | 1.25 | 1.25 | 1.3 | 1.4 | 1.85 |
| BPA normalizado diluido | 3.66653 | 5.91727 | 3.04653 | 3.6442 | 4.71815 | 7.36072 |
| Total Adjustments to Net Income | 1 | 0 | 1 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 4631 | 4870 | 4973 | 5213 | 5198 |
| Ingresos | 4631 | 4870 | 4973 | 5213 | 5198 |
| Coste de los ingresos, total | 1721 | 1813 | 1859 | 1959 | 1987 |
| Beneficio bruto | 2910 | 3057 | 3114 | 3254 | 3211 |
| Gastos totales de explotación | 3588 | 3821 | 3926 | 4174 | 4025 |
| Gastos de venta/general/administración Gastos, total | 1280 | 1342 | 1376 | 1546 | 1374 |
| Investigación y desarrollo | 574 | 585 | 660 | 590 | 586 |
| Gastos (ingresos) extraordinarios | 6 | 0 | -1 | -6 | 5 |
| Other Operating Expenses, Total | 7 | 81 | 32 | 85 | 73 |
| Ingresos de explotación | 1043 | 1049 | 1047 | 1039 | 1173 |
| Ingresos por intereses (gastos), netos No operativos | -60 | -95 | -54 | -47 | -34 |
| Otros, netos | 1 | 1 | |||
| Ingresos netos antes de impuestos | 984 | 955 | 993 | 992 | 1139 |
| Ingresos netos después de impuestos | 748 | 747 | 764 | 806 | 884 |
| Intereses menores | -1 | -2 | -3 | -4 | -3 |
| Beneficio neto antes de partidas extra. Elementos | 747 | 745 | 761 | 802 | 881 |
| Ingresos netos | 747 | 745 | 761 | 802 | 881 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 747 | 745 | 761 | 802 | 880 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 747 | 745 | 761 | 802 | 880 |
| Beneficio neto diluido | 747 | 745 | 761 | 802 | 880 |
| Promedio ponderado de acciones diluidas | 434.302 | 434.778 | 434.857 | 433.438 | 435.644 |
| BPA diluido sin partidas extraordinarias | 1.72 | 1.71352 | 1.75 | 1.85032 | 2.02 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 1.85 | 0 |
| BPA normalizado diluido | 1.80927 | 1.90422 | 1.8827 | 1.80908 | 2.07345 |
| Total Adjustments to Net Income | 0 | -1 |
- Anual
- Trimestral
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total Activo Corriente | 7670 | 7455 | 9236 | 9003 | 9280 | 10982 |
| Efectivo e inversiones a corto plazo | 981 | 623 | 2199 | 598 | 1234 | 1685 |
| Efectivo y Equivalentes | 662 | 481 | 779 | 541 | 1109 | 1511 |
| Inversiones a corto plazo | 319 | 142 | 1420 | 57 | 125 | 174 |
| Total deudores, neto | 3607 | 3707 | 3738 | 4233 | 3910 | 4345 |
| Accounts Receivable - Trade, Net | 2888 | 2923 | 3278 | 3644 | 3390 | 3853 |
| Total Inventory | 2609 | 2632 | 2764 | 3342 | 3294 | 3900 |
| Prepaid Expenses | 276 | 338 | 435 | 493 | 519 | 570 |
| Other Current Assets, Total | 197 | 155 | 100 | 337 | 323 | 482 |
| Total Assets | 38258 | 35621 | 36888 | 43811 | 41796 | 45362 |
| Property/Plant/Equipment, Total - Net | 4231 | 4512 | 4811 | 6213 | 6421 | 7217 |
| Property/Plant/Equipment, Total - Gross | 9404 | 9853 | 10551 | 12561 | 13228 | 14810 |
| Accumulated Depreciation, Total | -5172 | -5340 | -5740 | -6348 | -6808 | -7593 |
| Goodwill, Net | 15015 | 13582 | 13764 | 17141 | 15959 | 17004 |
| Intangibles, Net | 9980 | 8317 | 7237 | 9175 | 7653 | 7612 |
| Long Term Investments | 191 | 419 | 1 | 3 | ||
| Note Receivable - Long Term | 15 | 41 | 614 | 746 | 830 | 922 |
| Other Long Term Assets, Total | 1156 | 1295 | 1226 | 1533 | 1652 | 1622 |
| Total Current Liabilities | 9089 | 8635 | 8517 | 11842 | 9231 | 10432 |
| Accounts Payable | 2048 | 2195 | 1766 | 2054 | 1768 | 2380 |
| Accrued Expenses | 603 | 778 | 799 | 791 | 975 | 1204 |
| Notes Payable/Short Term Debt | 1855 | 1173 | 982 | 2224 | 515 | 1434 |
| Current Port. of LT Debt/Capital Leases | 1908 | 1590 | 1217 | 2307 | 1780 | 1062 |
| Other Current Liabilities, Total | 2675 | 2899 | 3753 | 4466 | 4193 | 4352 |
| Total Liabilities | 24269 | 21618 | 19688 | 25945 | 24850 | 24024 |
| Total Long Term Debt | 8706 | 7947 | 6608 | 8588 | 9745 | 8270 |
| Long Term Debt | 8706 | 7947 | 6608 | 8130 | 9418 | 7928 |
| Deferred Income Tax | 2724 | 1489 | 1288 | 1828 | 1441 | 1411 |
| Minority Interest | 61 | 63 | 33 | 48 | 71 | 78 |
| Other Liabilities, Total | 3689 | 3484 | 3242 | 3639 | 4362 | 3833 |
| Total Equity | 13989 | 14003 | 17200 | 17866 | 16946 | 21338 |
| Preferred Stock - Non Redeemable, Net | 397 | 397 | 397 | 397 | 397 | 397 |
| Common Stock | 168 | 168 | 168 | 168 | 168 | 168 |
| Additional Paid-In Capital | 3814 | 3814 | 3814 | 3814 | 3814 | 3814 |
| Retained Earnings (Accumulated Deficit) | 8049 | 9902 | 12532 | 13236 | 14556 | 16673 |
| Other Equity, Total | 1561 | -278 | 289 | 251 | -1989 | 286 |
| Total Liabilities & Shareholders’ Equity | 38258 | 35621 | 36888 | 43811 | 41796 | 45362 |
| Total Common Shares Outstanding | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 |
| Capital Lease Obligations | 458 | 327 | 342 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 10617 | 10182 | 10315 | 10982 | 11085 |
| Efectivo e inversiones a corto plazo | 2298 | 1870 | 1665 | 2073 | 1445 |
| Efectivo y Equivalentes | 2238 | 1825 | 1523 | 1899 | 1339 |
| Inversiones a corto plazo | 60 | 45 | 142 | 174 | 106 |
| Total deudores, neto | 4226 | 4124 | 4207 | 4345 | 4705 |
| Accounts Receivable - Trade, Net | 3816 | 3771 | 3930 | 3853 | 4345 |
| Total Inventory | 3462 | 3564 | 3760 | 3900 | 4143 |
| Other Current Assets, Total | 631 | 624 | 683 | 664 | 792 |
| Total Assets | 43891 | 43145 | 43836 | 45362 | 46235 |
| Property/Plant/Equipment, Total - Net | 6552 | 6601 | 6761 | 7217 | 7303 |
| Goodwill, Net | 16541 | 16347 | 16670 | 17004 | 17761 |
| Intangibles, Net | 7765 | 7613 | 7628 | 7612 | 7549 |
| Long Term Investments | 770 | 744 | 794 | 914 | 905 |
| Note Receivable - Long Term | 38 | 39 | 39 | 35 | 35 |
| Other Long Term Assets, Total | 1608 | 1619 | 1629 | 1598 | 1597 |
| Total Current Liabilities | 10652 | 9820 | 9793 | 10432 | 10207 |
| Accounts Payable | 1937 | 2107 | 2132 | 2380 | 2356 |
| Accrued Expenses | 118 | 144 | 191 | 224 | 174 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3347 | 3278 | 2770 | 2531 | 2345 |
| Other Current Liabilities, Total | 5250 | 4291 | 4700 | 5297 | 5332 |
| Total Liabilities | 24975 | 23852 | 23229 | 24024 | 23316 |
| Total Long Term Debt | 9001 | 8721 | 8195 | 8270 | 8286 |
| Long Term Debt | 9001 | 8721 | 8195 | 8270 | 8286 |
| Deferred Income Tax | 1440 | 1401 | 1374 | 1411 | 1389 |
| Minority Interest | 67 | 68 | 72 | 78 | 71 |
| Other Liabilities, Total | 3815 | 3842 | 3795 | 3833 | 3363 |
| Total Equity | 18916 | 19293 | 20607 | 21338 | 22919 |
| Preferred Stock - Non Redeemable, Net | 397 | 397 | 397 | 397 | |
| Common Stock | 168 | 168 | 168 | 168 | 565 |
| Additional Paid-In Capital | 3814 | 3814 | 3814 | 3814 | 3814 |
| Retained Earnings (Accumulated Deficit) | 15240 | 15799 | 16556 | 16673 | 18540 |
| Other Equity, Total | -703 | -885 | -328 | 286 | |
| Total Liabilities & Shareholders’ Equity | 43891 | 43145 | 43836 | 45362 | 46235 |
| Total Common Shares Outstanding | 434.778 | 434.778 | 434.778 | 434.778 | 434.778 |
- Anual
- Trimestral
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | 1633 | 2615 | 3396 | 1324 | 1994 | 3065 |
| Efectivo de actividades de explotación | 2510 | 2696 | 2219 | 2856 | 3477 | 4616 |
| Efectivo de actividades de explotación | 1934 | 1758 | 1812 | 1944 | 1938 | 1762 |
| Partidas no monetarias | -488 | -250 | -2523 | 149 | -59 | 62 |
| Cambios en el capital circulante | -569 | -1427 | -466 | -561 | -396 | -273 |
| Efectivo de actividades de inversión | -503 | -1147 | 2191 | -6153 | -1340 | -1578 |
| Gastos de capital | -848 | -1311 | -1016 | -1021 | -1563 | -1421 |
| Otras partidas de flujo de caja de inversión, total | 345 | 164 | 3207 | -5132 | 223 | -157 |
| Efectivo procedente de actividades de financiación | -1908 | -1870 | -2825 | 1902 | -1522 | -2504 |
| Elementos de flujo de caja de financiación | -464 | -469 | -607 | -527 | -519 | -576 |
| Total Cash Dividends Paid | -136 | -155 | -162 | -162 | -168 | -181 |
| Emisión (amortización) de deuda, neta | -1308 | -1246 | -2056 | 2591 | -835 | -1747 |
| Efectos del cambio de divisas | 8 | -30 | -5 | 5 | -40 | 9 |
| Variación neta de la tesorería | 107 | -351 | 1580 | -1390 | 575 | 543 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 748 | 1495 | 2258 | 3065 | 884 |
| Cash From Operating Activities | 1216 | 2104 | 3571 | 4616 | 840 |
| Cash From Operating Activities | 424 | 843 | 1287 | 1762 | 430 |
| Non-Cash Items | 6 | 25 | 46 | 62 | -24 |
| Changes in Working Capital | 38 | -259 | -20 | -273 | -450 |
| Cash From Investing Activities | -346 | -587 | -1226 | -1578 | -1089 |
| Capital Expenditures | -362 | -638 | -1155 | -1421 | -498 |
| Other Investing Cash Flow Items, Total | 16 | 51 | -71 | -157 | -591 |
| Cash From Financing Activities | 6 | -1054 | -2184 | -2504 | -315 |
| Financing Cash Flow Items | -55 | -575 | -575 | -576 | -100 |
| Total Cash Dividends Paid | 0 | -181 | -181 | -181 | 0 |
| Issuance (Retirement) of Debt, Net | 61 | -298 | -1428 | -1747 | -215 |
| Foreign Exchange Effects | 7 | 6 | 7 | 9 | 4 |
| Net Change in Cash | 883 | 469 | 168 | 543 | -560 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.8422 | 8842949 | 0 | 2022-09-27 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 4.84 | 6255325 | 3997581 | 2022-09-27 | LOW |
| Fidelity International | Investment Advisor | 3.0193 | 3902150 | 2587266 | 2022-09-19 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 2.9271 | 3783100 | -924069 | 2022-05-18 | LOW |
| Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.8682 | 3706864 | -407104 | 2022-12-14 | HIGH |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.8079 | 3629024 | 3672 | 2022-12-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.3464 | 3032598 | 488031 | 2022-12-31 | LOW |
| DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.9124 | 2471640 | 83238 | 2022-12-31 | LOW |
| FMR Investment Management (U.K.) Limited | Investment Advisor | 1.3005 | 1680776 | -5936 | 2022-12-31 | LOW |
| Deka Investment GmbH | Investment Advisor/Hedge Fund | 1.1334 | 1464775 | -25955 | 2022-12-31 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 1.1038 | 1426513 | 15622 | 2022-12-31 | LOW |
| Allianz Global Investors GmbH | Investment Advisor | 1.0531 | 1361000 | -28942 | 2022-11-30 | LOW |
| Union Investment Privatfonds GmbH | Investment Advisor | 0.9614 | 1242564 | 560959 | 2022-09-30 | LOW |
| Eleva Capital SAS | Investment Advisor | 0.8919 | 1152665 | 25800 | 2022-10-31 | HIGH |
| MFS International Singapore Pte. Ltd | Investment Advisor | 0.8661 | 1119411 | -22611 | 2022-12-31 | LOW |
| BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 0.8255 | 1066840 | -1655 | 2022-12-31 | LOW |
| Lazard Asset Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7985 | 1031971 | -21628 | 2022-12-31 | LOW |
| Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.7724 | 998279 | 69355 | 2023-01-31 | LOW |
| J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 0.7686 | 993311 | -119431 | 2022-09-30 | MED |
| California Public Employees' Retirement System | Pension Fund | 0.7543 | 974843 | -146711 | 2021-06-30 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group +500000+
Traders
93000+
Clientes activos mensualmente
$57000000+
Volumen mensual de inversión
$31000000+
Pruébalo ahora Retiros por mes
Calculadora de trading
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Comisión de la operación
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Apalancamiento
20:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Merck - EUR Company profile
Sobre Merck KGaA
Merck KGaA es una empresa de ciencia y tecnología con sede en Alemania. La empresa opera en tres segmentos de negocio: Salud, Ciencias de la Vida y Electrónica. El negocio de Sanidad, que opera en Estados Unidos y Canadá como EMD Serono, se centra en áreas terapéuticas como las alergias, la fertilidad, la oncología y las enfermedades neurodegenerativas, desarrollando medicamentos, sustancias de diagnóstico y dispositivos médicos. El negocio de Ciencias de la Vida comprende las actividades de MilliporeSigma, que ofrece soluciones que facilitan la investigación biotecnológica y farmacéutica. La gama de productos incluye sistemas de agua de laboratorio, herramientas de edición de genes, líneas celulares y sistemas de fabricación de medicamentos de principio a fin, entre otros. El negocio de Electrónica permite la vida digital y proporciona productos químicos especializados para diversas aplicaciones, como cristales líquidos para pantallas electrónicas, materiales para circuitos integrados, pigmentos de efecto para revestimientos y cosméticos de color, así como materiales funcionales para soluciones energéticas.
- IndustriaProprietary & Advanced Pharmaceuticals
- DirecciónFrankfurter Str. 250, DARMSTADT, Germany (DEU)
- Empleados60334
- CEOBelen Garijo
| Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com